Radius Health (RDUS) Tops Q1 EPS by 23c, Revenues Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 inches lower as Middle East tensions outweigh tech gains
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Radius Health, Inc.: First Quarter 2021 Results
May 7, 2021 6:30 AM EDTTotal net revenue: $56 million vs. $48 million in Q1, 2020, +17% year-over-yearTYMLOS® U.S. product net revenue: $45 million vs. $48 million in Q1, 2020, -6% year-over-yearSignificant operating leverage improvement: Q1, 2021 adjusted EBITDA: ($5) million vs. ($26) million in Q1, 2020Q1, 2021 EPS: ($0.34) vs. ($0.81) in Q1, 2020 Reiterating $250 million for full year 2021 net revenue guidance for the U.S. TYMLOS productHumana added TYMLOS to the formularies of its Medicare Advantage Plans on... More
